GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dannex Ayrton Starwin PLC (XGHA:DASPHARMA) » Definitions » EBITDA Margin %

Dannex Ayrton Starwin (XGHA:DASPHARMA) EBITDA Margin % : 0.00% (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Dannex Ayrton Starwin EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Dannex Ayrton Starwin's EBITDA for the six months ended in . 20 was GHS0.00 Mil. Dannex Ayrton Starwin's Revenue for the six months ended in . 20 was GHS0.00 Mil. Therefore, Dannex Ayrton Starwin's EBITDA margin for the quarter that ended in . 20 was 0.00%.


Dannex Ayrton Starwin EBITDA Margin % Historical Data

The historical data trend for Dannex Ayrton Starwin's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dannex Ayrton Starwin EBITDA Margin % Chart

Dannex Ayrton Starwin Annual Data
Trend
EBITDA Margin %

Dannex Ayrton Starwin Semi-Annual Data
EBITDA Margin %

Competitive Comparison of Dannex Ayrton Starwin's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Dannex Ayrton Starwin's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dannex Ayrton Starwin's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dannex Ayrton Starwin's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Dannex Ayrton Starwin's EBITDA Margin % falls into.



Dannex Ayrton Starwin EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Dannex Ayrton Starwin's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Dannex Ayrton Starwin's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dannex Ayrton Starwin  (XGHA:DASPHARMA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Dannex Ayrton Starwin EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Dannex Ayrton Starwin's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dannex Ayrton Starwin (XGHA:DASPHARMA) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.

Dannex Ayrton Starwin (XGHA:DASPHARMA) Headlines

No Headlines